Analyst Ratings for Ovid Therapeutics Inc (OVID)

OVID Rating Summary

OVID Price Target Summary

* Over Last 12-Mos
  |   Expand Research on OVID
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $5.00 (+13.4%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/20/2021 Cantor Fitzgerald Charles C. Duncan Downgrade Neutral
(Buy)
4.00
(N/A)
3.78
(4.41)
16.67% Details
3/3/2021 RBC Capital
» Updated 4/20/2021
Brian Abrahams Downgrade Sector Perform
(Outperform)
4.00
(5.00)
2.96
(4.41)
48.99% Details
Like OVID Ratings? Also take a look at TAK, FREE, NX, SFIX

OVID Ratings News